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By defining the chromosomal breakpoint of a balanced t(10;12) translocation from a subject with Kallmann syndrome and scanning
genes in its vicinity in unrelated hypogonadal subjects, we have identified WDR11 as a gene involved in human puberty. We found
six patients with a total of five different heterozygous WDR11 missense mutations, including three alterations (A435T, R448Q, and
H690Q) in WD domains important for b propeller formation and protein-protein interaction. In addition, we discovered that
WDR11 interacts with EMX1, a homeodomain transcription factor involved in the development of olfactory neurons, and thatmissense
alterations reduce or abolish this interaction. Our findings suggest that impaired pubertal development in these patients results from
a deficiency of productive WDR11 protein interaction.Introduction
Human puberty is a dynamic process that initiates
complex interactions of the hypothalamic-pituitary-
gonadal axis, the purpose of which is to produce sex
steroids for reproductive maturity and gametes for fertility.
Any disruption of the development or regulation of this
system, for which the hypothalamus serves as the master
regulator through its pulsatile release of gonadotropin-
releasing hormone (GnRH), can produce deleterious
consequences for successful reproduction.1 Patients with
idiopathic hypogonadotropic hypogonadism (IHH, MIM
146110) show clinical signs and symptoms of GnRH defi-
ciency: delayed puberty due to low sex steroid production
along with low levels of serum gonadotropins. Patients
with Kallmann syndrome (KS, MIM 308700, 147950,
244200, 610628, 612370, 612702) have IHH but also
display an impaired sense of smell, thought to be due to
the developmental failure of the migration of GnRH
neurons along the olfactory axonal projections.
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The Americhave used a variety of strategies to find IHH- and/or KS-
causing mutations in a number of genes. Such strategies
have included linkage analysis, deletion mapping, and
candidate gene analysis. The discovery of a rare family
with males displaying both X-linked KS and ichthyosis
led to the identification of KAL1 (MIM 308700) by posi-
tional cloning,2,3 and characterization of deletions4
and a balanced translocation5 involving chromosome 8
facilitated the cloning of FGFR1 (KAL2, MIM 136350),
associated with both IHH and KS.6 Positional cloning in
consanguineous autosomal-recessive IHH families revealed
KISS1R (MIM 604161) encoding GPR54,7,8 TAC39 (MIM
162330), and TACR39 (MIM 162332) and candidate-gene
approaches identified mutations in GNRHR10,11 (MIM
138850), NELF12 (MIM 608137), CHD7(KAL5)13 (MIM
608892), FGF8 (KAL6)14 (MIM 600483), and GNRH115,16
(MIM 152760); analogous mouse phenotypes pointed to
PROKR2 (KAL3)17 (MIM 607123), and PROK2 (KAL4)17
(MIM 607002), as well as KISS1R.8 Despite these significant
advances in the past two decades, however, the genetic
etiology remains unknown for about two-thirds of all
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Figure 1. Balanced Chromosome Translocation
and FISH Mapping of the Chromosome 10 Break-
point
(A) Ideogram and composite chromosomes illus-
trating the balanced t(10;12)(q26.12;q13.11)dn
(revised in this paper from the original karyotypic
assessment, t(10;12)(q26.3;q13.1)dn) in the KS
patient.
(B) FISH mapping with BAC clone RP11-254K03,
labeled with SpectrumGreen to metaphase spreads
of the KS patient, resulted in hybridization to the
normal chromosome 10, as well as the der(10) and
der(12) chromosomes, indicating that the transloca-
tion breakpoint of chromosome 10 is located within
the sequence of this BAC clone.To identify chromosomal rearrangements in IHH and KS
as a basis for disease gene identification, we previously kar-
yotyped 76 patients and found one male KS patient with
chromosome translocation reported as: 46,XY, t(10;12)
(q26.3;q13.1)dn (Figure 1A).18 The chromosome 10q26
region has been associated previously with abnormal
male genital development resulting from interstitial or
terminal deletions as well as a balanced translocation.
Abnormal development has included cryptorchidism,19,20
small testes,21 sperm defects and infertility,22 micropenis
and hypogonadism,23 hypogenitalism,24 and sparse sexual
hair.25 All of these phenotypic features overlap with char-
acteristics of IHH and KS. Importantly, a trisomy involving
10q26 has been reported in a KS patient with an unbal-
anced chromosome translocation,26 suggesting the pres-
ence of a new KS gene, which can involve dysregulation
as a result of either reduced or increased dosage, in this crit-
ical region. Therefore, we postulated that a single disease
gene disrupted or dysregulated by a position effect27 is
located at or near the 10q26 breakpoint in our KS patient
with a balanced translocation.Material and Methods
Patients
IHHwas diagnosed inmales who were 18 years old or younger and
had delayed puberty, testosterone levels <100 ng/dl (normal is466 The American Journal of Human Genetics 87, 465–479, October 8, 2010300–1100 ng/dl), and low or normal serum gonado-
tropins. In females, IHH was defined as primary
amenorrhea, nearly always with absent breast
development at R17 years of age and low estradiol
(<30 pg/ml).18,28 All patients had normal pituitary
function, including normal thyroid-stimulating
hormone, thyroxin, cortisol, and prolactin. No pitu-
itary tumor was present by radiographic imaging.
Complete IHH or KS is a more severe phenotype
defined as the complete lack of puberty with absent
breast development (Tanner 1) in females and testis
size %3 ml bilaterally in males. Incomplete IHH or
KS was defined as partial breast development in
females and testis sizeR 4 ml bilaterally in males.18
Olfaction was either tested with the University of
Pennyslvania Smell Identification Test when avail-able or documented by history. Lymphoblastoid cell lines were
generated from patients, and DNA, RNA, and/or protein was
extracted by standard methods as described previously.18 All
patients signed an informed consent approved by the Human
Assurance Committee of the Medical College of Georgia.
Tissue Culture and Lymphoblastoid Cell Lines
Epstein-Barr-virus-immortalized lymphoblastoid cell lines used in
this study were established from peripheral blood lymphocytes
of individuals. Once established, these cell lines were cultured
in RPMI 1640 (Mediatech) supplemented with 10% FCS, 2 mM
L-glutamine, and 0.017 mg/ml benzylpenicillin (CLS) and grown
at 37C with 5% CO2.
SNP Oligonucleotide Microarray Analysis
The Affymetrix Human Mapping 500K Array Set (Affymetrix,
Santa Clara, CA) is comprised of two arrays, each capable of geno-
typing on average 250,000 SNPs (approximately 262,000 for the
Nsp arrays and 238,000 for the Sty arrays). The mapping 500K
array set has a mean spacing of 5.8 kb. Specimens were assayed
with both arrays. The 500K assay was performed according to
the manufacturer’s protocol, beginning with 250 ng DNA. Ninety
mg of PCR product were fragmented and labeled. Hybridization
was carried out in the Affymetrix GeneChip hybridization oven
640. Posthybridization washing and processing were performed
with the Affymetrix GeneChip Fluidics Station 450. The arrays
were then scanned with the Affymetrix GeneChip Scanner 3000
7G. Image processing was performed with GCOS 1.4, and geno-
types were called with GTYPE 4.1 software and default settings.
Detection of copy-number changes was performed in the Chro-
mosome Copy Number Analysis Tool (CNAT) version 4.0, with
a reference set of 42 normal males. Data from the separate
Mapping 250K arrays were virtually combined after normalization
but before smoothing in CNAT 4.0.Fluorescence In Situ Hybridization Analysis
The clones were labeled with either SpectrumOrange or Spectrum
Green direct-labeled dUTP via the nick-translation Labeling Kit
(Abbott Molecular). The procedure involved incubation of the
DNA extracted from the clone with dATP, dCTP, dGTP, and fluores-
cent dUTP in the presence of DNA polymerase I and DNase I at
15C for 8–16 hr. Heating the mixture in a 70C water bath for
10 min stopped the reaction.
The slides from the harvested lymphoblastoid cell suspension
were prepared according to standard procedures. The cells on the
slides were denatured in 70% formamide and 23 SSC at 70C for
3 min and dehydrated serially in cold ethanol at increasing
concentrations up to absolute ethanol. The fluorescently labeled
probe mix was then applied to the slides, which were covered
with a coverslip and hybridized overnight in a moist chamber at
37C. After overnight hybridization, the slides were washed in
a solution of 43 SSC and 0.3% NP 40 at 72C for 2 min and
then washed with 23 SSC and 0.1% NP40 at room temperature
for 2 min. The metaphases were counterstained with 0.4 mg/ml
DAPI (4,6-diamidino-2-phenylindole) and analyzed under a fluo-
rescence microscope. The images were photographed with
a CCD camera with an Applied Imaging system.
Mouse In Situ Hybridization Analysis
Two primer pairs were used for amplification of two independent
Wdr11 probes spanning nucleotides 641–1035 and 2892–3492
of the murine Wdr11 transcript (NM_172255.3). The primers
used are listed in Table S4. Amplicons were ligated to a Topo-TA
vector (Invitrogen) and subcloned into pBluescript via EcoRI
and XbaI (restriction sites are underlined in Table S4). The probes
were labeled with [a-35S]UTP for hybridization on sections or
with Digoxigenin29 for whole-mount in situ hybridization as
well as for cryosections. Murine embryos were frozen on solid
CO2, and 10 mm sections were prepared on a cryostat. Adult
mouse brains were sectioned at 15 mm. Sections hybridized
with the [a-35S]UTP probe were exposed to Kodak Biomax MR
film for 3 days. No specific signals were detected with the
respective sense probes. Whole-mount in situ hybridization with
Digoxigenin-UTP-labeled probes was performed on total mouse
embryos with the in situ probe spanning nucleotides 2892–
3492. The day of plug was not counted for specification of embry-
onic stages.Isolation of Zebrafish wdr11 Gene and Whole-Mount
In Situ Hybridization
The zebrafish wdr11 gene (XM_682139.3) was isolated from the
24 hpf zebrafish cDNA library by RT-PCR with a BamHI-linked
forward primer and an NcoI-linked reverse primer (Table S4;
restriction sites are underlined), subcloned into the pGEM T-easy
vector, and then sequenced by automatic sequencer. To examine
the spatiotemporal expression patterns of wdr11, whole-mount
in situ hybridization was performed as previously described.30
Antisense digoxigenin-labeled RNA probes for wdr11 and emx131
were produced with a DIG-RNA labeling kit (Roche, Germany)
according to the manufacturer’s instructions.The AmericMutation Analysis
Genomic DNA extracted from 201 unrelated IHH and/or KS
patients was amplified with WDR11 primer pairs flanking the 29
exons and splice junction sites by nested PCR. Oligo 6.0 or Primer
3 was used for primer design, and conditions were optimized for
each PCR as described previously.11,13 Nested-PCR products were
electrophoresed on agarose gels, precipitated via ethanol, quanti-
fied, and sequenced with the Big Dye Terminator Kit (Applied
Biosystems; Foster City, CA).32 Sequencing reactions were purified
with Centrosep columns, lyophilized, and placed on an ABI 3730
automated DNA sequencer (Applied Biosystems; Foster City, CA).
All exons were sequenced at least twice; mutations were confirmed
3-4 times by independent PCR. Any putative mutation was
sequenced in >420 healthy white controls and >400 healthy
Turkish controls. The CodonCode Aligner Program (CodonCode
Corporation; Dedham, MA) was used for analysis of the
sequencing data.
Semiquantitative RT-PCR in Rat Tissue
Total RNAwas extracted from lymphoblastoid cell lines and tissues
with TRI Reagent (Molecular Research Center) and treated with
DNase I (QIAGEN). We primed 100 ng of RNA with gene-specific
primers by using Superscript III one-step RT-PCR kit (Invitrogen)
and Mastercycler Gradient (Eppendorf). Typical conditions were
as follows: 60C for 30min followed by 94C for 2min (one cycle),
then 94C for 15 s followed by 60C for 30 s and 68C for 50 s
(30 cycles). Then 68C for 5 min followed by cooling to 4C. For
semiquantitative RT-PCR analysis in rat tissues (Figure S1), we
used two primers to amplify nucleotides 2651–3357 of the rat
WDR11 transcript (XM_219377.5) (Table S4).
Yeast Two-hybrid Screening
For bait construction, a DNA fragment encoding amino acids
1–830 of WDR11 was subcloned into the BamHI and SalI sites of
pGBKT7 (Clontech). Approximately 5 3 106 transformants from
a mouse-brain cDNA library (Clontech) were screened in the
AH109 yeast strain. The positive colonies were confirmed with
b-galactosidase colony lift assays. The yeast plasmids were isolated
and transformed into Escherichia coli DH5a cells. We cotrans-
formed the isolated yeast DNA with a bait plasmid into AH109
to verify the interactions between WDR11 and the interacting
proteins.
Preparation ofWDR11 Mutant Constructs
A pFN21AA1351 clone that includedWDR11 open-reading frame
(ORF) sequence with the GenBank accession number of AB385454
was used for construction of theWDR11 mutant. DNA fragments
containing a nucleotide substitution were amplified by two-step
PCRs in which pFN21AA1351 served as a template; two separated
DNA fragments were amplified by the first PCR with one of the
mutant primers containing a nucleotide substitution (mR1 or
mF1 series) and the corresponding opposite outside primer (F01,
F06, R01 or R02), then two resultant amplified PCR products
were combined by the second PCR with the outside primers and
cloned into pUC118 vector. The cloned mutant DNA fragment
was cut with EcoNI for m1, m2, m3, and m4 constructs, and the
mutant EcoNI fragment was inserted between EcoNI sites of the
WDR11 ORF. For m5 and m6, the cloned DNA fragment was cut
with SwaI and PvuII, and the 1422 bp SwaI-PvuII fragment of
WDR11 was replaced with the mutant fragment. The sequences
of primers used for the construction are listed in Table S4.an Journal of Human Genetics 87, 465–479, October 8, 2010 467
Plasmid Construction
The full-length humanWDR11 and EMX1 clones were purchased
from Openbiosystems (clone ID 34306203 and 5260039, respec-
tively). The full ORFs of WDR11 and EMX1 were amplified from
purchased cDNA clones by PCR with specific primers, and the
DNA fragment was inserted into BamHI/NotI and EcoRI/XhoI sites
of pEntr3C, respectively. The Myc-WDR11, HA-EMX1, and GST-
EMX1 plasmids were constructed by Gateway Technology (Invi-
trogen) with pEntr-WDR11 and pEntr-EMX1.
Coimmunoprecipitation and Immunoblotting
Coimmunoprecipitation was performed after the lysis of 2 3
107 cells with lysis buffer (50mMHEPES, 150mMNaCl, 10% glyc-
erol, 1% Nonidet P-40, and 1 mM EDTA). After incubation on ice
for 10 min and centrifugation for 10 min at 4C, equal volumes of
protein were incubated overnight with antibody and protein A
G-Sepharose beads at 4C on a rotating wheel. The beads were
washed three times with lysis buffer. The whole-cell lysates
and immunoprecipitates were separated by SDS-PAGE and then
transferred onto polyvinylidene difluoride membranes. The
membranes were immunoblotted with anti-Myc (Invitrogen) or
anti-HA (Invitrogen) antibodies.
In Vitro Pull-Down Assays
The GST-fusion plasmids were expressed in E. coli. BL21(DE3) cells
and were purified with glutathione-Sepharose beads according to
the instructions of the manufacturer. The Myc-EMX1 proteins
were synthesized via the coupled TNT in vitro translation system
(Promega, Madison, WI). We performed pull-down assays by incu-
bating equal amounts of GST or GST-WDR11 fusion proteins
immobilized onto glutathione-Sepharose beads with in vitro
translated Myc-Emx1 and washing the beads three times with
phosphate-buffered saline and 0.5% Triton X-100. After washing,
the bound proteins were resolved by SDS-PAGE and detected via
immunoblotting with anti-Myc antibody.
Immunohistochemistry
U2OS cells were transfected with expression plasmids encoding
HA-EMX1 and GFP-WDR11. Twenty-four hours after transfection,
cells were treated with leptomycin B (10 ng/ml) for 12 hr before
being fixed with 4% paraformaldehyde for 5 min and incubated
with anti-HA antibody. Fluorescence microscopy was conducted
with a Zeiss Axioskop 2 microscope; excitation wavelengths of
543 nm (rhodamine red) and 488 nm (GFP) were used. The
acquired images were processed with Adobe Photoshop. For
subcellular localization for FCNB4-hTERT cells, approximately
2 ml of cell suspension was plated into each well of a microscopy
cover slide, incubated for 24 hr in a 37C CO2 incubator, and
then fixed with 4% paraformaldehyde (PFA) for 5 min at room
temperature. Cells were washed three times with PBS and permea-
bilized with 0.1% Triton X-100 in PBS for 5 min. After two washes
with PBS, nonspecific binding sites were blocked with 1% BSA
(Sigma) in PBS for 5 min. Samples were then rinsed with PBS
and incubated overnight at 4C with primary antibody. After
being washed with PBS, samples were incubated for 1 hr at room
temperature with the appropriate Alexa Fluor dye (Molecular
Probes)-coupled anti-rabbit 488 (green) or anti-mouse 589 (red)
secondary antibodies. After three PBS washes, nuclei were counter-
stained with To-pro3 (1 nM). Cover slips were mounted with anti-
fade vector shield (Molecular Probe) reagent and viewed with the
Zeiss LSM 510 Meta Confocal Microscope.468 The American Journal of Human Genetics 87, 465–479, OctoberExon Trapping
We used the exon-trapping system (Invitrogen GIBCO) to investi-
gate the effect of the heterozygous c.2932A>C nucleotide variant
(p.K978Q) in the acceptor splice site of exon 24 of WDR11.
A genomic fragment of 2411 bp encompassing exons 23–25 along
with flanking intronic sequences and a 1286 bp fragment
comprising exon 25 along with flanking intronic sequences were
amplified by PCR with two primer pairs (Table S4). The resulting
PCR products were cloned into exon-trapping vector pSPL3 via
restriction sites EcoRI (50 end) and BamHI (30 end). We verified
sequences for all constructs to exclude PCR-induced mutations
and to select constructs with or without the splice site variant
c.2932A>C (p.K978Q). COS-7 cells were grown in 100 mm dishes
in DMEM (Invitrogen) supplemented with 10% fetal calf serum
(Invitrogen) in a 10% CO2 atmosphere at 37
C. At approximately
60% confluency, cells were each transfected with 8 mg of exon-
trapping construct DNA via Lipofectamine 2000 (Invitrogen).
Cells were collected 30 hr after transfection, and cytoplasmic
RNA was isolated with RNeasy (QIAGEN) according to the manu-
facturer’s instructions. After transcription into cDNA via Omni-
script Reverse Transcriptase (QIAGEN), two rounds of PCR with
vector-specific oligonucleotides were performed. PCR products
were subcloned into TA cloning vector pCR2.1-Topo (Invitrogen)
and directly sequenced with the ABI BigDye Terminator
Sequencing Kit (Applied Biosystems) and the automated capillary
sequencer ABI 3130 (Applied Biosystems).
Anti-WDR11 Antibody Generation
A new WDR11 polyclonal antibody was generated against the
N-terminal residues 32–48 of NP_060587.8 (QGLIAYGCHSLVV
VIDS); an N-terminal cysteine was added for conjugation
purposes. Rabbits were injected with Freund’s adjuvant containing
the peptide sequence. After the second bleed, affinity purification
was performed. The peptide sequence used fop raising the anti-
body was conserved in ten species (human, chimpanzee, cow,
horse, panda, pig, dog, rat, mouse, and rabbit).
Array Painting
Flow-sorting of metaphase chromosomes was performed as
described previously.33 Both derivative chromosomes were ampli-
fied with the GenomiPhi V2 DNA Amplification kit (GE Health-
care, Piscataway, NJ, USA) according to the manufacturer’s
protocol. One microgram of each amplification product was
labeled with Cy3 or Cy5 via Agilent’s Genomic DNA Enzymatic
Labeling Kit Plus (Agilent). To each labeling reaction, adding 100
ng of genomic control DNA ensured proper placement of the
grid after image analysis. A customized oligonucleotide array
that represented chromosomal regions chr10:121,855,186–122,
255,228 and chr12:45,828,906–46,226,893 (hg18) was designed
by means of eArray (Agilent, Santa Clara, CA); there was an
average oligonucleotide spacing of 200–300 bases. Hybridization
and washing steps were performed as previously described.34
Quantitative Real-Time RT-PCR (RT-qPCR) ofWDR11
in the t(10;12) Patient
cDNA from lymphoblastoid cells was used for real-time RT-qPCR
with the StepOnePlus Real-Time PCR system (Applied Biosystems)
and Power SYBR Green PCR Master Mix (Applied Biosystems) and
two primer pairs (WDR11-1:3117forwardþ3213reverse;WDR11-2:
3221forwardþ3370reverse; Table S4). RT-qPCR was performed in
triplicate with same amount of cDNA, and WDR11 levels were8, 2010
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Figure 2. Genetic Mapping of the 10q26 Locus Involved in IHH and KS
(A) The translocation breakpoint, depicted as a crocodile head, is located between SEC23IP and PPAPDC1A. Horizontal bars at 10q26.12
show BACs used for FISHmapping. The size and location of BACs are to scale. The blue bar depicts a BAC clone spanning the breakpoint.
Four positional candidate genes located proximal and distal to the breakpoint are shown as arrows in a 2 Mb region.
(B) Exon and intron structure of the 58 kb gene WDR11 (NM_018117.11). Locations of human missense mutations are identified in
sporadic IHH and KS patients. Notable exons are shown to scale as blue rectangles and are numbered with exon size. The sizes of introns
are not to scale. Mutation F1150L was identified in two independent sporadic IHH patients.normalized to GAPDH expression. WDR11 levels in t(10;12) were
normalized to those in a male control with StepOne Software
(Applied Biosystems).
Immunoblot Analysis of WDR11 in the t(10;12)
Patient
Cells were washed with PBS twice and lysed in RIPA buffer
(PIERCE) containing completeEDTA-freeprotease inhibitor (Roche
Diagnostics). Total cellular lysates were separated by SDS-polyacry-
lamide gel electrophoresis and transferred to nitrocellulose
membranes. Membranes were incubated with primary antibody
overnight at 4C.Membranes were washedwith TBS-T buffer three
times and incubated with a secondary antibody conjugated to
horseradish peroxidase for 2 hr at room temperature. After three
washeswith TBS-T buffer, the blotswere visualized by an enhanced
chemiluminescence method (GE Healthcare).Results
Delineation of the Breakpoint Region on 10q26
Affymetrix Human Mapping 500K Array SNP oligonucleo-
tide microarray analysis (SOMA) of patient DNA wasThe Americconsistent with a balanced translocation and excluded
copy-number variation (CNV) as the cause of the IHH or
KS phenotype (data not shown). To identify the potentially
disrupted genes, we first mapped the translocation break-
points by using fluorescence in situ hybridization (FISH).
Two BAC clones, RP11-592D19 in 10q25.3 and RP11-
91E2 in 10q26.3, mapped as centromeric and telomeric,
respectively, to the chromosome 10 breakpoint and thus
flanked it within a 16.4 Mb region. Sequential rounds of
FISH with BACs within this region narrowed the candidate
region until a breakpoint-crossing BAC clone was identi-
fied. Of nineteen BACs examined, three were proximal
and fifteen were distal to the breakpoint, whereas RP11-
254K03 hybridized to the normal chromosome 10 and
both der(10) and der(12) chromosomes, indicating that it
spans the translocation breakpoint, as shown in Figures
1B and 2A.Delineation of the Breakpoint Region on 12q13
BAC clones RP11-88L2 from 12q12 and RP11-762I7 from
12q13.2, used as starting clones for FISH,mapped proximalan Journal of Human Genetics 87, 465–479, October 8, 2010 469
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Figure 3. Sequences of the Translocation Breakpoints and
Protein Sequence Alignment of WDR11 Orthologs
(A) Genomic DNA sequence at the breakpoints from the normal
and derivative chromosomes. The breakpoint on chromosome
10 is located between nucleotides 122,053,649 and 122,053,650,
whereas on chromosome 12 it occurs between nucleotides
46,038,271 and 46,038,272 (UCSC Genome Browser NCBI
hg18). The junction sequence reveals a 4 bp duplication at the
breakpoint of the der(10) chromosome and a 1 bp deletion and
a 57 bp insertion at the junction on the der(12) chromosome.
(B) ClustalW multiple alignment of partial protein sequences of
WDR11 orthologs. The positions of three residues affected by
missense mutations of WDR11 are marked by arrows and red
letters in the corresponding segments of the multiple alignment.
The amino acid residues that differ from the sequence of the
human WDR11 protein are indicated in blue, and the ninth WD
domain is indicated under the panel. All three mutated residues
are evolutionarily fully conserved in all 13 available WDR11
orthologs.and distal, respectively, to the breakpoint, confining the
chromosome 12 breakpoint within an 11.7 Mb region.
FISH experiments with twenty BACs within the region
revealed twelve proximal and seven distal to the break-
point, as well as RP11-464D5, which hybridized to the nor-
mal chromosome 12 and both der(10) and der(12) chromo-
somes, indicating that it spans the translocationbreakpoint
(data not shown). Sequencing of the breakpoint cloned as
described below confirmed localization of the junction
sequence within RP11-464D5, as shown in Figure 3A.
Refining the Breakpoint Regions by Array Painting
and Cloning of Junction Fragments
After narrowing down both breakpoint regions by FISH
and before finding the breakpoint spanning clones, we per-
formed array painting by using a customized oligonucleo-470 The American Journal of Human Genetics 87, 465–479, Octobertide array that represented chromosomal regions chr10:
121,855,186–122,255,228 and chr12:45,828,906–46,226,
893 (hg18) with an average oligonucleotide spacing of
200–300 bases to determine the breakpoint regions more
precisely and eventually clone the junction fragments.
Based upon the array-painting results, the breakpoint
regions were refined to 2.7 kb (between nucleotide posi-
tions 122,053,148 and 122,055,901) in 10q26.12 and
4.2 kb (between nucleotide positions 46,034,656 and
46,038,863 in 12q13.11) (UCSC Genome Browser, NCBI
Build 36/hg18 assembly), resulting in restatement of the
previously cytogenetically assigned karyotype to 46,XY,
t(10;12)(q26.12;q13.11)dn. Five forward primers (12q13.2-
10kb-4208f, -4562f, -5338f, -5961f, and -7351f) designed
from 10 kb containing the 4.2 kb breakpoint region at
12q13.11 and three reverse primers (10q26-10kb-3497r,
-5710r, and -5750r) designed from 10 kb encompassing
the 2.7 kb breakpoint region at 10q26.12 were paired
in a long-range PCR (QIAGEN LongRange PCR Kit 250).
Annealing was performed at 60C for 30 s with an exten-
sion for 7 min. All fifteen PCR reactions produced
amplicons with sizes from 1.7–7.1 kb (consistent with
the interprimer distances on each chromosome) from the
subject’s DNA but not from that of a normal control
male. Therefore, the breakpoints at 10q26.12 and
12q13.11 were narrowed to 590 bp and 2.2 kb, respec-
tively, confirming the array-painting result. Finally, the
junction fragment of ~1.8 kb from der(12) was amplified
by normal PCR from one primer pair of 12q13.2-10kb-
7351forward and 10q26-10kb-3497reverse and confirmed
by sequencing and subsequent BLAST searching.
To amplify the junction fragment of der(10), we paired
five forward primers (10q26-10kb -1851f, -2367f, -2801f,
-2851f, and -2914f) designed from the 10 kb breakpoint
region at 10q26 and five reverse primers (12q13.2-10kb-
7630r, -8180r, -8836r, -9664r, and -9890r) from the 10 kb
breakpoint region at 12q13.2 in a long-range PCR, which
produced amplicons of 1–2.5 kb in combinations with
two of the reverse primers (12q13.2-10kb-9664r and
-9890r) but no amplicons with the other three (12q13.2-
10kb-7630r, -8180r, and -8836r), further refining the break-
point region. The 2 kb junction fragment of der(10) was
amplified by primer set 10q26-10kb-2367f and 12q13.2-
10kb-9890r. The partial sequences from chromosomes
10 and 12 of this junction fragment were confirmed by
sequencing and BLAST searching. The breakpoint on chro-
mosome 12 is located between nucleotides 46,038,271 and
46,038,272, whereas on chromosome 10 it occurs between
nucleotides 122,053,649 and 122,053,650, 547 kb from
the 50end of WDR11. At the junction of the der(10) frag-
ment, there was a CTTT duplication, and at the junction
of der(12) fragment, there was a 1 bp G deletion and a
57 bp insertion (Figure 3A).
Candidate Gene Expression Pattern in Rat
The translocation did not directly disrupt a gene on either
chromosome 10 or 12, but on the basis of the common8, 2010
chromosomal location associated with IHH and KS pheno-
types, we hypothesized that 10q26 was more likely to
harbor the causative gene; therefore, we did not study
the 12q region further.
On 10q26.12, four candidate genes (FGFR2, PPAPDC1A,
SEC23IP, and WDR11) were present in the vicinity of the
breakpoint (Figure 2A). We examined their expression in
the rat ovary, testis, olfactory bulb, hypothalamic preoptic
area, medial basal hypothalamus, anterior pituitary, piri-
form cortex, temporal cortex, prefrontal cortex, hippo-
campus, and cerebellum using semiquantitative RT-PCR
analysis. All four genes were expressed in all tissues
tested; the highest Wdr11 (XM_219377.5) expression, in
decreasing order, was in the ovary, olfactory bulb, and piri-
form cortex (Figure S1).
Mutation Screening of Positional Candidate Genes
We screened 123 IHH and KS patients for FGFR2 (MIM
176943) mutations by direct sequencing of all coding
exons and splice junctions (exons 2–18 of NM_022970.3
and the additional exon 8 of NM_000141.4) and found
only known polymorphisms rs755793, rs1047100,
rs3135774, rs41293763, and rs2278202. Exons 1–7 of
PPAPDC1A (NM_001030059.1) were directly sequenced
in 60 IHH or KS patients and were likewise negative
for mutations other than reported polymorphisms
rs10886691 and rs1047369 and additional synonymous
variants F15F, L194L, and P270P. Exons 1–18 of SEC23IP
(NM_007190.2) were screened in 120 IHH or KS patients.
Only known polymorphisms rs34157476, rs3859163,
rs3740569, rs3740570, rs17099368, rs34824340, rs2475298,
rs2271123, rs12771873, rs58111481, and rs34826964 were
seen as variants. Additionally, heterozygous c.760G>T of
SEC23IP (p. V254F) was identified in one KS female and
two IHHmales butnot ina secondKS femalewithin a family,
indicating a lack of segregation with IHH or KS and suggest-
ing that it is a rare sequence variant (absent from182normal
white controls). Furthermore, heterozygous c.1191þ38A>C
identified in a male IHH patient was inherited from one of
two healthy parents, both of whom are heterozygous for
the same change, suggesting that it is also a polymorphism.
DNA sequencing of the protein-coding exons and splice
junctions of theWDR11 gene with 29 exons (NM_018117.
11, MIM 606417) was performed in 201 IHH or KS patients.
Five different heterozygous missense variants that appear
to be pathogenic mutations were identified in six unre-
lated probands (3%) (Table 1); none of these variants was
present in R420 normal white controls or an additional
402 ethnically matched controls for the one proband
who is of Turkish origin. Interestingly, the putative
WDR11 mutations were found in both IHH (n ¼ 5) and
KS (n ¼ 1) patients, as shown in Table 1, and are described
below. We identified one additional heterozygous change,
c.2932A>C (p.K978Q), in a Turkish male IHH patient.
Residue K978 is completely conserved in all 13 higher
vertebrates (Figure S2) and this same nucleotide change
was not identified in an initial set of 180 white and TurkishThe Americcontrols. Although the K978Q alteration involves a base
change in the first nucleotide of exon 24, exon-trapping
experiments did not reveal any aberrant splicing in vitro
(data not shown), suggesting that the variant does not
affect splicing differences in vivo. Sequencing of additional
Turkish control subjects identified the c.2932A>C variant
in two Turkish controls (2/402). Thus, c.2932A>C
(p.K978Q) is a sequence variant that is not sufficient to
cause IHH or KS and has the characteristics of a rare poly-
morphism (Table S1). Whether it is associated with
increased risk of IHH or KS will require investigation of
additional IHH, KS, and ethnically matched control
subjects.
The five putative heterozygous missense variants that
were observed in IHH and KS patients but absent from all
controls are c.1183C>T (p.R395W) in an IHH male,
c.1303G>A (p.A435T) in a Turkish IHH male, c.1343G>A
(p.R448Q) in an IHH female, c.2070T>A (p.H690Q) in
a KS male, and c.3450T>G (p.F1150L) in one male and
one female IHH patient. Three of the missense changes
altering amino acid residues R395, H690, and F1150 are
completely conserved in all higher vertebrates (Figure 3B).
Two unrelated patients had an identical heterozygous
missense alteration, F1150L, so we performed haplotype
analysis with seven informative SNP markers—rs7077126,
rs10886800, rs41287988, rs1045154, rs12259815, rs10871,
and rs1045170—from theWDR11 30-UTR region.Genotyp-
ing of these two patients (C17 and C100) indicated that
they share a haplotype around WDR11 and are therefore
likely to be descended from a recent common ancestor
(data not shown). All identified SNPs, including ten novel
SNPs inWDR11, are listed in Table S1.
RT-qPCR and Immunoblot Analysis ofWDR11
in the t(10;12) Patient
RT-qPCR and immunoblot analysis with antibody that we
generated demonstrated reductions of approximately 20%
for transcript and 10% for WDR11 in the lymphoblast cell
line from our translocation patient compared to two
gender-matched controls (Figure S3). Because this line
has one normal allele and one translocated allele, if the
entire effect were due to reduction of the mRNA from
the translocated chromosome, as would be suspected, the
20% overall reduction in transcript would correspond to
an approximate 40% reduction in expression from the
translocated chromosome. Although this reduction is
modest, it does demonstrate proof-of-principle for a poten-
tial position effect of the breakpoint, which is about 547 kb
50 of WDR11. It is conceivable that, because of tissue-
specific factors, the magnitude of the reduction might be
significantly greater in some other tissues of the transloca-
tion subject, especially those tissues involved in the neuro-
endocrine control of reproduction, but it is not possible to
measure this directly because the lymphoblasts represent
the only tissue available from the subject. However, the
small effect in lymphoblasts is consistent with an effect
of the translocation on expression of this gene andan Journal of Human Genetics 87, 465–479, October 8, 2010 471
Table 1. WDR11 Mutations in IHH and KS Patients
Patient
Gender and
Phenotype
Geographic
Origin
Location
(Exon/Intron)
Nucleotide
change
(NM_018117.11)
Amino Acid
Change
(NP_060587.8)
Class of
Mutation Confirmatory Method
C37 Male/KS; complete
IHH; anosmia;testes,
1 ml bilaterally
United States Translocation
breakpoint is
547 kb away
from the 50
end of WDR11
_ _ chromosomal
structure mutation
as a balanced
translocation-
t(10;12)
(q26.12;q13.11)dn
FISH, array painting,
and sequencing of
junction fragment;
de novo.
C71 Male/complete IHH;
testes, 2 ml; FSH ¼
3 mIU/ml; LH ¼
1.2 mIU/ml
United States Exon 8 c.1183C>T R395W missense 0/420 white controls;
detrimental in protein
modeling; invariant
in 13 available WDR11
orthologs.
T87 Male/IHH; complete
IHH; bilat
cryptorchidism;
FSH ¼ 0.3 mIU/ml;
LH < 0.3 mIU/ml
Turkey Exon 10 c.1303G>A A435T missense 0/426 white controls;
0/402 Turkish controls;
within sixth WD domain;
detrimental in protein
modeling; abolished
EMX1 binding.
C99 Female/IHH United States Exon 10 c.1343G>A R448Q missense 0/426 white controls;
within sixth WD domain;
detrimental in protein
modeling; reduced EMX1
binding; predicted to
destabilize the WDR11
dimer and impair actin
binding of the complex.
C127 Male/KS; anosmia United States Exon 16 c.2070T>A H690Q missense 0/420 white controls;
within ninth WD
domain; detrimental
in protein modeling;
abolished EMX1 binding;
invariant in 13 available
WDR11 orthologs.
C17 Male/IHH; incomplete
IHH; testes, 35, 25 ml;
FSH ¼ 6 mIU/ml
United States Exon 28 c.3450T>G F1150L missense 0/420 white controls;
invariant in 13 available
WDR11 orthologs.
C100 Female/IHH; complete
IHH; breasts: Tanner 1;
FSH < 1 mIU/ml;
LH < 1 mIU/ml
United States Exon 28 c.3450T>G F1150L missense 0/420 white controls;
invariant in 13 available
WDR11 orthologs.
Complete IHH refers to the complete absence of sexual development, whereas incomplete IHH indicates partial pubertal development. Testis size is given (normal
is 15–25 ml) when available. Breast development is given when available—Tanner 1 indicates no breast buds.therefore with its role in generating the phenotype in this
patient.
Protein Structure Modeling of WDR11
To explore the potential structural features of WDR11, we
generated a protein model by using multiple sequence
alignment (ClustalW35) based on homology to the C. ele-
gans Homolog of Yeast Actin Interacting Protein 1 (AIP1)
(PDB code 1NR0),36 shown in Figure S4. The close struc-
tural similarity of the model of WDR11, which features
two b propeller structures in each protein chain36,37 (Fig-
ure 4A), with the AIP1 dimer (PDB code 1PGU), indicates
that WDR11 will also be an actin-binding protein38
(Figure S4). WDR11 contains twelve WD domains, nine
(second to tenth repeats) that are confirmed on the basis
of direct comparison with the template structure of AIP1
(Figures 4A and 4B) and three additional repeats (first,
11th, and 12th) detected by sequence comparison outside472 The American Journal of Human Genetics 87, 465–479, Octoberthe region of the structural model (Figures 4A and 4B;
Table S2). Like AIP1, WDR11 is predicted to exhibit two
b propellers; WD domains 2–6 are predicted to constitute
the first, andWD domains 7–10 are predicted to constitute
the second (Figure 4A). The structural model for WDR11
overlaps well with the known AIP1 structure (Figure S4).
This model predicts that WDR11 has twelve WD domains
and that nine of them (second through tenth) participate
in the genesis of two consecutive b propellers.
WDR11 Interacts and Colocalizes with EMX1
In Vivo and In Vitro
WDR11 is a 1,224 amino acid protein that contains
multiple WD domains likely to mediate interaction with
protein-binding partners (NCBI Conserved Domain Data-
base cl02567). Consequently, we performed a yeast two-
hybrid screen to identify potential cellular proteins whose
interaction with WDR11 might be disrupted by the8, 2010
AB
Figure 4. WDR11 Structural Model Indi-
cating the Mutation Sites
(A) Model spanning amino acids 70–739 of
WDR11. The model was obtained by align-
ment to 1NR0 via ClustalW and MOE
(Molecular Operating Environment [MOE
2004.03], Chemical Computing Group,
Montreal, Quebec, Canada H3B 3X3).
WDR11 forms a double propeller structure,
in which the WD domains indicated in (B)
form the main structural constituent. The
two propeller axes are tilted with respect
to one another, so only the propeller struc-
ture on the left is clearly visible in this
representation. Colors indicate side chains
of the four mutations within the modeled
sequence region, as follows: WD domains
predicted on the basis of the model
(green), on the basis of SMART (pink), or
both (cyan). The sites of the mutations
are indicated in orange.
(B) Positions of five missense mutations in
WDR11; WD domains are depicted as
ovals. The WD domains predicted on the
basis of the model and by SMART are
depicted in green and pink, respectively.
The relative sizes and locations of WD
domains are to scale. WDR11 contains
twelveWD domains, nine (second to tenth
repeats) that are confirmed on the basis of
direct comparison with the template struc-
ture of AIP1 and three additional repeats
(first, 11th, and 12th) detected by sequence
comparison outside the region of the struc-
tural model. Note that three mutations
directly affect WD domains 6 and 9.apparent missense mutations in IHH and KS patients. We
identified EMX1 (MIM 600034), a human ortholog of
Drosophila ems (empty spiracles), as a WDR11-interacting
protein. Although four other proteins, including Hey1
(hairy/enhancer-of-split related with YRPW motif 1, MIM
602953), Tagln2 (Transgelin 2, MIM 604634), Ndrg4
(N-Myc downstream-regulated gene 4), and Nrxn3 (neu-
rexin 3, MIM 600567) were also identified as potential
WDR11 binding partners, we focused on EMX1 for further
studies because of its functional relevance to the devel-
oping nervous system.39–43
Specific interaction between WDR11 and EMX1 was
revealed by cotransformation of yeast with an expression
plasmid encodingWDR11 fused to the GAL4 DNA-binding
domain and a plasmid encoding EMX1 fused to the
GAL4 activation domain (Figure 5A). The interaction was
confirmed in mammalian cells by coimmunoprecipitation
assays, which demonstrated that HA-tagged EMX1 was
recovered from immunoprecipitates of coexpressed Myc-
WDR11 (Figure 5B), and further confirmed by GST pull-
down analysis (Figure 5C).
To define the particular WDR11 domains necessary for
interaction with EMX1, we generated WDR11 deletion
mutants and performed GST pull-down assays to assess
EMX1 binding. Both the N terminus and the central
portion of WDR11 bound to EMX1, whereas the
C terminus did not (Figure 5E). We next tested whetherThe Americany of the four missense mutations in the N terminus
and the central region of WDR11 interfered with EMX1
binding in vitro. Coimmunoprecipitation of EMX1 with
the translated proteins from each of the four WDR11
mutant constructs demonstrated that mutants 2 (A435T)
and 4 (H690Q) did not associate with EMX1 in mamma-
lian cells, whereas mutant 3 (R448Q) reduced, but did
not eliminate, the EMX1 binding. Mutant 1 (R395W)
had no effect upon EMX1 binding (Figure 5F).
Subcellular Localization of WDR11 and EMX1
Because EMX1 is a homeodomain transcription factor that
participates in the development of olfactory neurons,40 we
examined the subcellular localization of both EMX1 and
WDR11 in a physiologically relevant human cell system.
Immunostaining with a polyclonal anti-WDR11 antibody
(directed to N-terminal residues 32–48 of NP_060587.8:
QGLIAYGCHSLVVVIDS) localized WDR11 to the cyto-
plasm of FCNB4-hTERT cells, immortalized human embry-
onic olfactory GnRH neuroblasts isolated from olfactory
epithelium of an 8- to 12-week-old human embryo
(data not shown).44 Similarly, fluorescence microscopy of
GFP-WDR11 transfected into U2OS cells also yielded a
cytoplasmic localization, whereas HA-EMX1 localized to
the nucleus. However, when these cells were treated
with leptomycin B, an inhibitor of nuclear export, both
HA-EMX1 and GFP-WDR11 colocalized in the nucleusan Journal of Human Genetics 87, 465–479, October 8, 2010 473
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Figure 5. The WDR11 Interacts and Co-
localizes with EMX1 In Vivo and In Vitro
(A) EMX1 was identified in the yeast two-
hybrid screen as a WDR11-interacting
protein. The specific interactions between
these two proteins were confirmed by
streaking of transformed yeast cells onto
synthetic drop-out plates lacking TL (Trp/
Leu) or TLH (Trp/Leu/His). Yeast AH109
cells were transformed with empty vectors
(pGBKT7 and pGAD), and plasmids encod-
ing SV40 T antigen (pTD1) and p53
(pGBKT7-p53) were utilized as a negative
and positive control, respectively.
(B) Myc-WDR11 expression plasmids were
transfected alone or along with HA-EMX1
into HeLa cells, the cell lysates were
immunoprecipitated with anti-Myc anti-
body, and coprecipitated HA-EMX1 was
detected via immunoblotting with anti-
HA antibody.
(C) In-vitro-translated Myc-EMX1 was
subjected to GST pull-down analysis with
GST (lane 2) or GST-WDR11 (lane 3). The
bound proteins were detected via immu-
noblotting with anti-Myc antibody.
(D) HA-EMX1 and GFP-WDR11 expression
plasmids were transfected into U2OS cells,
and then cells were treated with leptomy-
cin B (LMB), an inhibitor of nuclear export.
Fluorescence microscopy analysis helped
determine localizations of HA-EMX1 and
GFP-WDR11. Nuclei were stained with
DAPI.
(E) Wild-typeMyc-WDR11 and its deletion
mutants were synthesized in vitro and sub-
jected to a GST pull-down assay with GST
(center panel) or GST-WDR11 (right panel). The N,M, and C denote theWDR11N terminus (amino acids 1–361),middle portion (amino
acids 362–830), and C terminus (amino acids 831–1224), respectively. The positions of missensemutations foundwithin the N terminus
and central region of WDR11 in IHH patients are marked as m1 through m4 on the schematic diagrams of WDR11.
(F) The wild-type andmissensemutantWDR11 expression plasmids were transfected into HEK293 cells alongwith HA-EMX1 expression
plasmids. The cell lysates were immunoprecipitated with anti-Myc antibody, and the association of EMX1 with wild-type WDR11 or
missense mutants was determined via immunoblot analysis with anti-HA antibody.(Figure 5D), suggesting that WDR11 might be shuttling
between the nucleus and cytoplasm. When each of the
five WDR11 missense mutants was transfected into
FCNB4-hTERT cells, none altered subcellular localization
of the protein (data not shown).
Mouse and Zebrafish Whole-Mount In Situ
Hybridization
To investigate the developmental expression ofWdr11, we
performed whole-mount in situ hybridization analysis in
mouse embryos from days E10.5–E14.5. The pattern of
expression observed was consistent with a role for
WDR11 in IHH and KS. As early as E10.5, the entire devel-
oping central nervous system, except for the spinal
cord, revealedWdr11 expression (Figures 6A–6C). The neu-
roepithelium, including the diencephalic region that gives
rise to hypothalamic neurons where GnRH neurons reside,
stained strongly for Wdr11 at E11.5 and E12.5. Mouse
neuroendocrine GnRH neurons migrate from the olfactory
placode region alongside olfactory neurons to cross the
cribriform plate and finally reach the hypothalamus,474 The American Journal of Human Genetics 87, 465–479, Octobera process that is active from E10.5–E14.5 and is usually
completed by E18.5.45 At E14.5 high levels of Wdr11
expression were particularly noteworthy in the developing
cortex and the olfactory bulb (Figures 6D and 6E). In the
adult brain, intense Wdr11 expression was restricted to
the olfactory bulb, the olfaction-related piriform cortex
(Figure 6F), the granule cell layer of the cerebellum, and
neurons of the hippocampal formation (Figure 6G).
Increased signal intensities within the hypothalamus
were observed with 35S-UTP labeled Wdr11 antisense
probes (Figure 6G). For higher-resolution images of this
region, digoxigenin labeling of sagittal sections of adult
brains demonstrated signals scattered throughout the
hypothalamus, sometimes in clusters of neurons
(Figure 6H). Notably, in mouse, Emx1 expression is also
detectable from day 9.5 of gestation in the presumptive
cerebral cortex and olfactory bulbs.46
In the zebrafish, wdr11 was expressed ubiquitously at
24 hpf; whereas emx1 was highly expressed in the fore-
brain, and a small group of cells was clustered around
the same area of the diencephalic GnRH3 neurons at8, 2010
Figure 7. Expression of wdr11 in Developing Zebrafish Embryos
At 24 hpf, wdr11 transcripts were broadly detected in forebrain,
midbrain, and hindbrain.
(A, B, and E) Lateral view; anterior is to the left. (C and D) Dorsal
view. The expression domain of wdr11 in the brain partially over-
lappedwith that of emx1 (B and D), a dorsal telencephalonmarker.
Abbreviations are as follows: dt, dorsal telencephalon; f, forebrain;
m, midbrain; h, hindbrain; mhb, midbrain-hindbrain boundary;
vt, ventral telencephalon; and ret, retina.
Figure 6. Wdr11 Expression during Murine Development
(A–E) DIG-labeled whole-mount in situ hybridization with a
Wdr11 antisense probe at different embryonic stages. High expres-
sion levels are found in all structures of the developing brain as
early as E10.5. Expression in the limbs is prominent at E12.5
and E13.5. Staining was also observed in both the hind and
forelimb buds, but as limbs developed, it shifted toward the
terminal phalanges. At E14.5 the olfactory bulb and the devel-
oping cortex show the highest expression levels. A magnification
of the developing cortex and olfactory bulb is shown in (E).
(F–H) Expression of Wdr11 in the adult brain. [35S]-UTP-labeled
in situ hybridizations show prominent Wdr11 signals in the piri-
form cortex (F) as well as in the hippocampus and cerebellum
(G). Note the higher signal intensity in the hypothalamic region
within the dotted rectangle in (G). Single cells as well as clusters
of neurons within the hypothalamic nuclei also showed Wdr11
expression in DIG-labeled cryosections (H). Signals were absent
with the sense control. Abbreviations are as follows: tel, telence-
phalic vesicle; wh, wall of hindbrain; di, diencephalon; mes,
mesencephalon; rho, rhombencephalon; sc, spinal cord; lb, limb
bud; hl, hind limb; fl, fore limb; ob, olfactory bulb; pc, piriform
cortex; gcl, granule cell layer of the cerebellum; hp, hippocampus;
and hy, hypothalamus.30–36 hpf (Figure 7), again consistent with a potential role
for a WDR11-EMX1 protein interaction.Discussion
Our mapping, cloning, and sequencing of the breakpoints
of the de novo balanced chromosome translocation from
a KS male with karyotype 46,XY,t(10;12)(q26.12;q13.11)
dn and the consequent detection of multiple independent
missense variants inWDR11 in KS and IHH patients argues
strongly for a causative role for WDR11 in this disorder.
Regrettably, DNA samples of the patients’ parents are notThe Americavailable, and all efforts to track the parents have been
unsuccessful. However, because all WDR11 mutations
were heterozygous, autosomal-dominant inheritance of
the IHH phenotype is likely. Consistent with this interpre-
tation, noWDR11mutation was found in any of 29 exons
or splice junctions on the untranslocated second allele
from our translocation patient, suggesting that a reduction
in functional WDR11 as a result of dysregulation of the
gene via a position effect of the translocation is the cause
of KS in this subject (see Results and Figure S3). The
absence of truncating nonsense and frameshift mutations
indicates that these might produce a more severe pheno-
type or embryonic lethality.
WDR11 was originally identified as a potential tumor
suppressor by positional cloning of a somatically acquired
t(10;19) chromosome translocation that generated an
intragenic deletion in human glioblastoma cells.47 This
deletion disrupted WDR11 and fused it to the ZNF320
gene (MIM 606427). Interestingly, other genes associated
withmammalian puberty are also known for their involve-
ment in tumorigenesis.48 For example, hypothalamic
expression of certain tumor suppressor genes is increased
at puberty in monkeys or decreased in mice with delayed
puberty.49 Similarly, KISS1 (MIM 603286), a tumor metas-
tasis suppressor gene50 in melanomas51 and breast carci-
nomas52 encodes the peptide ligand of G-protein-coupledan Journal of Human Genetics 87, 465–479, October 8, 2010 475
receptor 54 (GPR54),53 which plays a critical role in the
initiation of puberty. KISS1R (encoding GPR54) mutations
cause autosomal-recessive IHH in consanguineous families
and mice.7,8
WDR11’s function is unknown, but it contains twelve
WD domains and is highly conserved throughout verte-
brate evolution. The gene was previously annotated as
BRWD2 (Bromodomain and WD repeat domain contain-
ing 2) but has recently beenmore appropriately designated
WDR11 because it has WD domains but no Bromo
domains.54 Mutations of other WD proteins have been
associated previously with mammalian reproduction.
Both genders of Repro5 mice, which have ENU-induced
Brwd1 (Wdr9) mutations, demonstrate infertility. In addi-
tion, patients with mutations of BRWD3 (MIM 300553)
have undescended testes and minimal facial or axillary
hair.55 However, this is the first report of a specific role
for a WD protein in IHH or KS, and it implicates protein-
protein interaction mediated by WD repeats of WDR11
as a critical requirement for normal puberty.
Proteins with repeated WD domains, each of which
consists of four antiparallel b strands, form b propeller
structures to support interactions with protein-binding
partners and to organize and stabilize multiprotein
complexes.56 A b propeller is characterized by 4–8 blade-
shaped b sheets arranged around a central axis; each sheet
of four antiparallel b strands is twisted so that the first and
fourth sheets are close to perpendicular. The last b strand of
one WD repeat, and the first three b strands of the WD
repeat form a blade of the b propeller (Figure 4A).
Three of the WDR11 missense mutations leading to
R395W, H690Q, and F1150L alter amino acid residues
that are completely conserved in all 13 available mamma-
lian and avian orthologs (human, chimpanzee, cow,
horse, panda, pig, dog, rat, mouse, rabbit, opossum,
chicken, and finch), and a fourth change, A435T, is shared
in 11 out of 13 species, suggesting that these substitutions
in six independent sporadic patients are very to be detri-
mental. Three of the missense alterations are located
directly in the predicted propeller regions of WDR11:
A435T and R448Q are in the sixth WD domain, and
H690Q is in the ninth WD domain (Figure 4B). These
three mutations are predicted by SPPIDER to alter pro-
tein-protein binding domains defined by protein model-
ing and therefore are likely to disrupt normal protein
function (Figure S5).
The similarity in structural modeling between WDR11
and the known structure of AIP1 suggests that WDR11,
like AIP1, may form a dimer stabilized by interaction
with two zinc ions (Figure S6). Because the two protein
structures are not identical, deviations arising from their
alignment make the position of the Zn ion uncertain to
a few angstroms (Figure S4). However, WDR11 has the
required residues (Asp377, Glu384, His501, His508, and
Glu510) for zinc binding in the vicinity of the putative
zinc position (Figure S7). The R448Q mutation is less
than 5 A˚ from the predicted zinc binding site. Arg residues476 The American Journal of Human Genetics 87, 465–479, Octobernear Zn coordination sites do not directly interact with the
Zn, but they stabilize their environment because Arg is
highly positively charged. Replacing Arg with the much
smaller Gln residue could influence the zinc-binding
propensity of WDR11 and affect its dimer formation and
interactions, including a potential actin interaction pre-
dicted by analogy with AIP1.57
In view of the importance of protein-protein interac-
tions for the function of WD proteins, we sought binding
partners for WDR11 and identified the transcription factor
EMX1 as a novel interactor. EMX1 is a homeobox tran-
scription factor involved in specifying cell fates in the
developing central nervous system,39 and it participates
in the development of olfactory neurons.40 This putative
transcription factor has been shown to be one of the down-
stream target genes for Gli-Kruppel family member 3 (Gli3,
MIM 165240) transcription factor,41,42 which is a part of
the Sonic hedgehog-Patched-Gli (Shh-Ptch-Gli) signaling
pathway43 important in endocrine signaling.
Analysis of the expression patterns ofWDR11 in human
embryonic olfactory GnRH neuroblasts as well as in mouse
and zebrafish development revealed overlapping patterns
of expression with EMX1 in regions critical for formation
of the hypothalamus,45 supporting the opportunity for
the two proteins to interact in vivo and to act together
during development. Deletion analysis revealed that
WDR11 interacts with EMX1 via both its N terminus
and its central region, where four (R395W, A435T,
R448Q, and H690Q) of the five WDR11 missense alter-
ations were found. R448Q reduced and both A435T and
H690Q abolished binding to EMX1, physically decreasing
the opportunity for productive interaction. Interestingly,
the mutant R395W did not appear to affect EMX1
binding, but this represents alteration of an amino acid
that is invariant in higher vertebrates, suggesting that
this alteration permits binding but impairs the as-yet-
undefined functional consequences of the WDR11-EMX1
interaction.
Taken together, our genetic and functional data provide
strong evidence for missense sequence variants ofWDR11
as a cause of IHH and KS in a proportion of cases of this
genetically heterogeneous condition. This adds to the
growing list of genes known to be mutated in IHH and
KS and will open new investigative routes for under-
standing the development of normal human puberty and
reproduction. Importantly, the identification of EMX1 as
a binding partner of WDR11 whose interaction can be dis-
rupted by IHH- and KS-associated mutations is significant
for two principal reasons. First, it places WDR11, whose
biological function is not well understood, as a potential
player in the Sonic hedgehog-Patched-Gli-Emx signaling
pathway via its interaction with EMX1. Second, the
demonstration of a developmental role for WDR11 in
IHH and KS suggests a possible connection between Shh
signaling and pubertal development. The potential for
defects in this pathway in IHH and KS is worthy of further
exploration.8, 2010
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